US 11291667
Combination therapy involving diaryl macrocyclic compounds
granted A61KA61K31/506A61K31/517
Quick answer
US patent 11291667 (Combination therapy involving diaryl macrocyclic compounds) held by TURNING POINT THERAPEUTICS, INC. expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TURNING POINT THERAPEUTICS, INC.
- Grant date
- Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/506, A61K31/517, A61K31/519, A61K31/5377